Ignite Creation Date:
2025-12-24 @ 5:36 PM
Ignite Modification Date:
2025-12-27 @ 8:50 AM
Study NCT ID:
NCT01715168
Status:
UNKNOWN
Last Update Posted:
2015-01-15
First Post:
2012-10-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer
Sponsor:
Azaya Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-10
Start Date Type:
None
Primary Completion Date:
2015-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2015-12
Completion Date Type:
ESTIMATED
First Submit Date:
2012-10-19
First Submit QC Date:
None
Study First Post Date:
2012-10-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-01-13
Last Update Post Date:
2015-01-15
Last Update Post Date Type:
ESTIMATED